Company / Gross Margin
Innoviva, Inc. Gross Margin History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Margin
74.8%
FY2025
5-year range
74.8% / 82.6%
FY2023-FY2025
Trend
-9.4%
vs FY2024
Sector context
#10 of 28
Health Care
What the data says
At 74.8%, Innoviva, Inc.'s gross margin ranks #10 of 28 in the Health Care sector. Gross Margin remained relatively stable over the past 3 years, with values between 74.8% and 82.6%.
Based on SEC 10-K filings.
74.8% in FY2025.
Declined from 79.3% to 74.8% over the past 2 years.
Health Care sector context is included.
Gross Margin over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -
- 10-Year Change
- -
Sector benchmark
#10 of 28 in Health CareTop 36% of 28This company 74.8% Sector average 60.3%
▼
+24.1% above sector average
Key checks
Key Insights
- In FY2025, gross margin decreased 9.4% year-over-year.
- Currently 14.5pp above the Health Care sector average.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 74.8% | -9.4% |
| FY2024 | 82.6% | +4.2% |
| FY2023 | 79.3% | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026